To date, 25 patients with ZAP-70 deficiency underwent HCT have been reported, with 91.7% surviving at a median follow-up of 36 months, compared to 59.1% at a median follow-up of 18 months for those without HCT. This evidence concerns the gene ZAP70 and hyperinsulinemic hypoglycemia, familial, 4.